ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MDC Mediclinic International Plc

501.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mediclinic International Plc LSE:MDC London Ordinary Share GB00B8HX8Z88 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 501.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

RMB Morgan Stanley Limited Form 8 (DD) - AMENDMENT - Mediclinic Intl plc (2749X)

22/11/2017 4:01pm

UK Regulatory


Mediclinic (LSE:MDC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Mediclinic Charts.

TIDMMDC

RNS Number : 2749X

RMB Morgan Stanley Limited

22 November 2017

AMMENT

The Panel executive has agreed on an ex parte basis that the below trading has no code consequences

FORM 8 (DD)

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:                                 RMB Morgan Stanley (Pty) Ltd 
----------------------------------------------------------  ---------------------------------------------------------- 
 (b) Owner or controller of interests and short positions 
 disclosed, if different from 1(a): 
 The naming of nominee or vehicle companies is 
 insufficient. For a trust, the trustee(s), 
 settlor and beneficiaries must be named. 
----------------------------------------------------------  ---------------------------------------------------------- 
 (c) Name of offeror/offeree in relation to whose relevant   Mediclinic International plc 
 securities this form relates: 
 Use a separate form for each offeror/offeree 
----------------------------------------------------------  ---------------------------------------------------------- 
 (d) Status of person making the disclosure:                 person acting in concert with the offeror (Mediclinic 
 e.g. offeror, offeree, person acting in concert with the    International plc) 
 offeror/offeree (specify name of 
 offeror/offeree) 
----------------------------------------------------------  ---------------------------------------------------------- 
 (e) Date dealing undertaken:                                17 November 2017 
----------------------------------------------------------  ---------------------------------------------------------- 
 (f) In addition to the company in 1(c) above, is the        YES 
 discloser making disclosures in respect                      If YES, specify which: 
 of any other party to the offer?                             Spire Healthcare Group plc 
 If it is a cash offer or possible cash offer, state "N/A" 
----------------------------------------------------------  ---------------------------------------------------------- 
 
   2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 
 Class of relevant security:                                                                  10p ordinary 
-------------------------------------------------------------------------------  ------------------------------------- 
                                                                                     Interests        Short positions 
-------------------------------------------------------------------------------  -----------------  ------------------ 
                                                                                   Number      %       Number      % 
-------------------------------------------------------------------------------  ----------  -----  -----------  ----- 
 (1) Relevant securities owned and/or controlled:                                  100,877    0.01   1,306,285    0.18 
-------------------------------------------------------------------------------  ----------  -----  -----------  ----- 
 (2) Cash-settled derivatives:                                                    1,657,006   0.22    352,832     0.05 
-------------------------------------------------------------------------------  ----------  -----  -----------  ----- 
 (3) Stock-settled derivatives (including options) and agreements to 
 purchase/sell: 
-------------------------------------------------------------------------------  ----------  -----  -----------  ----- 
 
   TOTAL:                                                                         1,757,883   0.24   1,659,117    0.23 
-------------------------------------------------------------------------------  ----------  -----  -----------  ----- 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   (b)        Rights to subscribe for new securities (including directors' and other employee options) 
 
 Class of relevant security in relation to which subscription right exists: 
---------------------------------------------------------------------------- 
 Details, including nature of the rights concerned and relevant percentages: 
---------------------------------------------------------------------------- 
 
   3.         DEALINGS BY THE PERSON MAKING THE DISCLOSURE 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

   (a)        Purchases and sales 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 
 Class of relevant security    Purchase/sale    Number of securities   Price per unit 
                                                                            (ZAR) 
----------------------------  ---------------  ---------------------  --------------- 
        10p ordinary                SALE               5,000              103.710 
----------------------------  ---------------  ---------------------  --------------- 
 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 
   Class of relevant      Purchases/ sales       Total number of       Highest price per unit   Lowest price per unit 
        security                                   securities              paid/received            paid/received 
-----------------------  -----------------  ------------------------  -----------------------  ----------------------- 
 
 
   (b)        Cash-settled derivative transactions 
 
   Class of relevant      Product description      Nature of dealing       Number of reference    Price per unit (ZAR) 
        security                e.g. CFD         e.g. opening/closing a        securities 
                                                  long/short position, 
                                                 increasing/reducing a 
                                                  long/short position 
-----------------------  ---------------------  -----------------------  ----------------------  --------------------- 
      10p ordinary                CFD                     LONG                    5,000                 103.710 
-----------------------  ---------------------  -----------------------  ----------------------  --------------------- 
 
   (c)        Stock-settled derivative transactions (including options) 
   (i)         Writing, selling, purchasing or varying 
 
   Class of       Product        Writing,      Number of       Exercise          Type       Expiry date   Option money 
   relevant     description    purchasing,     securities      price per         e.g.                        paid/ 
   security      e.g. call       selling,       to which         unit         American,                   received per 
                   option      varying etc.      option                        European                       unit 
                                                relates                          etc. 
-------------  -------------  -------------  -------------  --------------  -------------  ------------  ------------- 
 
 
   (ii)        Exercise 
 
   Class of relevant      Product description   Exercising/ exercised    Number of securities     Exercise price per 
        security            e.g. call option           against                                           unit 
-----------------------  --------------------  -----------------------  ---------------------  ----------------------- 
 
 
   (d)        Other dealings (including subscribing for new securities) 
 
 Class of relevant security         Nature of dealing          Details   Price per unit (if applicable) 
                               e.g. subscription, conversion 
---------------------------  -------------------------------  --------  ------------------------------- 
 
 
   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the party to the offer or person acting in concert making the 
  disclosure and any other person: 
  Irrevocable commitments and letters of intent should not be included. If there are no such 
  agreements, arrangements or understandings, state "none" 
-------------------------------------------------------------------------------------------- 
 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the party 
  to the offer or person acting in concert making the disclosure and any other person relating 
  to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
---------------------------------------------------------------------------------------------- 
 
 
   (c)        Attachments 

Are any Supplemental Forms attached?

 
 Supplemental Form 8 (Open Positions)   NO 
-------------------------------------  --- 
 Supplemental Form 8 (SBL)              NO 
-------------------------------------  --- 
 
 
 Date of disclosure:    22 November 2017 
---------------------  ------------------ 
 Contact name:          Craig Horsley 
---------------------  ------------------ 
 Telephone number:      +44(141) 245 7736 
---------------------  ------------------ 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DCCFEUFIEFWSEIF

(END) Dow Jones Newswires

November 22, 2017 11:01 ET (16:01 GMT)

1 Year Mediclinic Chart

1 Year Mediclinic Chart

1 Month Mediclinic Chart

1 Month Mediclinic Chart

Your Recent History

Delayed Upgrade Clock